Stock ENTA ENANTA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-05-03 EDT 		5-day change 1st Jan Change
15.17 USD +9.06% Intraday chart for Enanta Pharmaceuticals, Inc. +22.64% +61.21%
04-30 Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer CI
02-09 Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ENANTA PHARMACEUTICALS, INC. Stock Enanta Pharmaceuticals, Inc.
 321M - - -
MODERNA, INC. Stock Moderna, Inc.
 47.9B -
LONZA GROUP AG Stock Lonza Group AG
 41.42B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 40.7B
CELLTRION, INC. Stock Celltrion, Inc.
 28.92B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 25.55B
  1. Stock Market
  2. Equities
  3. ENTA Stock
  4. Charts Enanta Pharmaceuticals, Inc.
  5. Sector Chart